Delivery Order SPE2DR25D2101-SPE2DR26F46BG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,480.40 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a delivery order valued at $2,498.31 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed price delivery order, issued on December 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.11 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, a prescription medication used to treat high cholesterol. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,595.00 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price, competitive delivery order was issued on November 14, 2025, with an ultimate completion date of November 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $12,845.91 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector medication. This contract, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,743.99 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. The contract, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a firm fixed-price delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. No set-aside designation was applied to this competitive award. AmerisourceBergen, headquartered...
- The Defense Logistics Agency (DLA) awarded a $3,901.00 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with completion targeted for December 5, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the location of performance—is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $3,405.33 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order was issued on September 25, 2025, with an ultimate completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,513.48 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a specialty pharmaceutical product for cholesterol management. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 11, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,461.62 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. The contract, which became effective on November 25, 2025, with completion scheduled for November 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, drawing from its substantial Indefinite Delivery...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46BGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,570.00 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick autoinjectors, a prescription medication used to treat high cholesterol. This competitive, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a child order under the company's larger pharmaceutical supply agreement with DLA. This delivery order falls under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a broad range of medications, vaccines, and medical supplies to support military healthcare systems and the Defense Health Agency. The company's significant market position and demonstrated capability to fulfill federal medical procurement requirements through competitive awards make it a primary supplier within DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 12/1/25 |